How to adjust dosages when ADHD and bipolar co-occur?

PostedNovember 20, 2025

UpdatedNovember 21, 2025

ByMy Patient Advice

Author: Harriet Winslow, BSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

Living with both ADHD and bipolar disorder can make treatment planning more complex, as each condition affects brain chemistry differently. According to NICE guidance on ADHD (NG87) and bipolar disorder (CG185), careful sequencing and dosage management are essential to prevent one treatment from worsening the other. The goal is to stabilise mood symptoms first before adding or adjusting ADHD medication. The NHS also note that treatment plans should be personalised and regularly reviewed by a specialist team.

Managing Co-occurring ADHD and Bipolar Disorder: Medication Sequencing and Dosage

When ADHD and bipolar disorder occur together, managing both safely requires a stepwise approach. This means stabilising bipolar disorder first, then introducing ADHD medication cautiously. The main aim is to avoid triggering mania or mood instability from stimulant drugs. According to the BMJ, sequencing of treatment is one of the most critical steps for ensuring stability and reducing relapse.

Stepwise management and sequencing

NICE recommends that clinicians stabilise bipolar symptoms using a mood stabiliser or atypical antipsychotic before introducing ADHD medication. Evidence from the NHS shows that stimulants such as methylphenidate or lisdexamfetamine should only be started when the patient is already mood stable. Introducing both medications at once is discouraged, as this increases the risk of mood destabilisation and makes it difficult to monitor individual drug effects.

Mood stabilisers and antipsychotics

Common first-line treatments for mood stabilisation include lithium, valproate, lamotrigine, and atypical antipsychotics such as quetiapine, aripiprazole or olanzapine. According to NICE’s bipolar guidance, these medicines help reduce manic symptoms and prevent stimulant-induced relapse. Valproate should be used cautiously in people under 55 and only under specialist agreement if no safer alternative exists.

Safe ADHD medication initiation and dosage adjustment

Once bipolar disorder is stable, ADHD medication can be started at a low dose and titrated carefully. Research from PubMed (2025) shows that when a mood stabiliser is in place, stimulants do not significantly increase the risk of mania. Non-stimulant options such as atomoxetine or guanfacine can be used if stimulants are unsuitable. Regular reviews are essential during the adjustment phase to track both focus and mood symptoms.

Risks and monitoring

Main risks include mood destabilisation, manic or hypomanic episodes and rapid cycling. Frequent clinical reviews, weekly at first, then monthly, are advised, with additional cardiovascular and ECG checks when necessary. Collaborative care between psychiatrists, GPs and mental health nurses supports consistent monitoring and early intervention if symptoms shift.

Key takeaway

When ADHD and bipolar disorder co-occur, treatment must start with stabilising mood. Only once bipolar symptoms are controlled should ADHD medication be added, and always at a low, closely monitored dose. Following NICE and NHS advice ensures that care remains safe and effective for adults and young people.

Harriet Winslow, BSc

Author

Harriet Winslow is a clinical psychologist with a Bachelor’s in Clinical Psychology and extensive experience in behaviour therapy and developmental disorders. She has worked with children and adolescents with ADHD, autism spectrum disorder (ASD), learning disabilities, and behavioural challenges, providing individual and group therapy using evidence-based approaches such as CBT and DBT. Dr. Winslow has developed and implemented personalised treatment plans, conducted formal and informal assessments, and delivered crisis intervention for clients in need of urgent mental health care. Her expertise spans assessment, treatment planning, and behavioural intervention for both neurodevelopmental and mental health conditions.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.